Zurich Cantonal Bank’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,790
Closed -$195K 2708
2024
Q4
$195K Buy
15,790
+2,049
+15% +$23.5K ﹤0.01% 2163
2024
Q3
$156K Hold
13,741
﹤0.01% 2237
2024
Q2
$98.1K Buy
13,741
+3,041
+28% +$23.3K ﹤0.01% 2377
2024
Q1
$71.7K Hold
10,700
﹤0.01% 2495
2023
Q4
$69.5K Hold
10,700
﹤0.01% 2548
2023
Q3
$101K Hold
10,700
﹤0.01% 2349
2023
Q2
$149K Sell
10,700
-2,645
-20% -$45.1K ﹤0.01% 2113
2023
Q1
$250K Buy
13,345
+3,686
+38% +$60.5K ﹤0.01% 1733
2022
Q4
$133K Buy
9,659
+154
+2% +$2.36K ﹤0.01% 2087
2022
Q3
$182K Hold
9,505
﹤0.01% 1814
2022
Q2
$145K Hold
9,505
﹤0.01% 1984
2022
Q1
$194K Buy
9,505
+2,061
+28% +$42K ﹤0.01% 1906
2021
Q4
$217K Hold
7,444
﹤0.01% 2016
2021
Q3
$161K Hold
7,444
﹤0.01% 2059
2021
Q2
$191K Buy
+7,444
New +$159K ﹤0.01% 1840

Other funds holding CDMO

Zurich Cantonal Bank's CDMO Position: Q1 2025 in Review

Zurich Cantonal Bank sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 15,790 shares — an estimated $195K sold.

Zurich Cantonal Bank first reported a position in CDMO in Q2 2021 and held it in 15 quarters. The position peaked at $250K in Q1 2023. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Zurich Cantonal Bank reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 15,790 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $195K.
  • Zurich Cantonal Bank first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2021 and held it in 15 quarters.
  • Zurich Cantonal Bank's Avid Bioservices, Inc. Common Stock position peaked at $250K in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Zurich Cantonal Bank's 13F filing for Q1 2025, filed 7 May 2025.